Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Ortho is an emerging Orthobiologics company dedicated to the development of novel therapeutic soft tissue repair technologies to dramatically improve the success rate of sports medicine surgeries. Our proprietary RESTORE technology platform, is a muco-adhesive CHITOSAN based biopolymer matrix, which in the case of Ortho-R, is mixed with patient conditioned plasma of a concentrate of proteins/growth factors (Platelet-Rich Plasma or “PRP”)  to deliver biologics to increase the healing rates of occupational and sports related injuries to tendons, meniscus, ligaments and cartilage. The polymer-biologics hybrid combination can be directly applied into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention. Considering the significant bioactivity and residency of our proprietary biopolymer, Ortho continues to assess its potential for therapeutic uses outside of the soft tissue repair. Further information about Ortho is available on the Company's website at www.orthorti.com and on SEDAR at www.sedar.com. Also follow us on LinkedIn and Twitter.

Ovation Science Inc. (CSE:OVAT / OTCQB:OVATF) develops topical and transdermal products with Invisicare®, a high performance, patented drug delivery system that is backed by 20+ years of R&D and enhances the delivery of ingredients to and through the skin.  We are all about the science!

Using pharmaceutical drug development protocols and innovation, Ovation Science has developed products in two unique categories:  (1) topical and transdermal cannabis product formulations and (2) our unique hand sanitizer DermSafe® made without alcohol. Our technology and formulations are licensed to national and international companies that are branding experts that manufacture and market these products globally.

Pac Roots Cannabis Corp. (a late-stage Cannabis Act applicant) is the future of genetics. By focusing on elite cannabis genetic development, the Company maximizes the quality of its products, by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners; Phenome One, one of the largest live genetic libraries in Canada with over 350+ live cultivars as well as their JV partnership with Rock Creek Farms and Speakeasy Cannabis Club which leverages existing infrastructure, equipment, and access to land on a 100-acre Hemp Project. This combination has the company positioned to be cash-flow positive within their first year of trading. 

Peakbirch is a multi-brand management company providing services & related products to the cannabis industry that believes its strong focus on and investment in marketing, brand, education to help customers make sound purchasing decision, strategic brand partnerships, and a delivery software technology will create a business with the potential to generate a significant and sustained return on invested capital over the long-term.

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs.  The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, a Dutch company building a modern adult use psychedelic retail business with an elevated and educational focus. PharmaDrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through regulatory and research driven clinical trials.such as psychedelics, cannabis and naturally-derived approved drugs.  The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, a Dutch company building a modern adult use psychedelic retail business with an elevated and educational focus. PharmaDrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through regulatory and research driven clinical trials.

 

PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company focused on the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative and pain disorders.

As an innovative, vertically integrated and established cannabis leader in the Nevada market, Planet 13 Holdings, Inc. is committed to providing an array of international award-winning cannabis products available through its strategically located licensed operations. Planet 13 Holdings, Inc. is focused on providing an unparalleled dispensary experience and optimizing cultivation efficiencies through its best-in-class technology, as the vanguard of cannabis.

 

Planet 13 Holdings Inc. 02FEB2023 Warrants: Each Warrant entitles the holder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire one (1) Warrant Share upon payment of the Exercise Price of $9.00.

See the Warrant Indenture for full details.

Planet 13 Holdings Inc. 05NOV2022 Warrants: Each Warrant entitles the holder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire one (1) Warrant Share upon payment of the Exercise Price of $5.80.

See the Warrant Indenture for full details.

Planet 13 Holdings Inc. 10SEP2022 Warrants: Each Warrant entitles the holder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire one (1) Warrant Share upon payment of the Exercise Price of $5.00.

See the Warrant Indenture for full details.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Advertisement

Publicité